NUWE$5.24+1.06%
Nuwellis, Inc.
Sector: Electromedical & Electrotherapeutic ApparatusIndustry: Medical - DevicesCountry: USExchange: Nasdaq
Mkt Cap:$2.12M
Float & O/S:405.1K / 405.3K
Inst Own:0.6%
DilutionScan read 36 of Nuwellis, Inc.'s SEC filings and found 22 warrant series, 3 convertibles, 1 ATM program, 3 shelf registrations, 4 S-1 registrations and 5 completed offerings on file for NUWE. The latest dilution event on file is a registration statement on Aug 26, 2026. Analysis updated Oct 27, 2026.
Signal8 Summary
5d old
NUWE
Going-concern warning, two reverse splits this year
- Business
- WeakNet loss $17.5M vs $8.3M revenue, runway 5.5 months
- Stock risk
- HighMicro-cap, two reverse splits, 72% dilution overhang
Snapshot
Nuwellis is a tiny medical-device maker whose FY 2025 revenue of $8.3M fell 5.4% YoY, with a $17.5M net loss, more than double revenue.
What's Happening Right Now
- : Nuwellis announced acceptance of its ULTRA-Peds Registry study (91 pediatric patients, 87% survival) in Pediatric Nephrology, backing a proposed FDA label expansion of Aquadex down to patients weighing 5 kg.
- : Nuwellis filed an 8-K for a 1-for-9 reverse stock split effective October 26, 2026, its second reverse split in four months, typically done to regain Nasdaq compliance.
- : Nuwellis closed a $3.4M registered direct offering and private placement in August 2026 at $2.59/share (a steep discount to the prior close) and registered the resale of warrant shares that could lift shares outstanding by roughly 37%.
- : Registered 150K shares for sale on Form S-3.
- : Nuwellis signed a co-promotion and distribution agreement with Atrility Medical for the AtriAmp device, a pilot that could lead to Nuwellis becoming its exclusive U.S. distributor.
- : Nuwellis' Q2 10-Q disclosed substantial doubt about continuing as a going concern, a $325.7M accumulated deficit, a stockholders' deficit below Nasdaq's minimum equity requirement, and two material weaknesses in internal controls, despite a narrower $4.8M net loss and 76.1% gross margin.
- : Raised $3.40M in gross proceeds through a registered direct offering, with warrants over 150K shares.
- : Raised $3.30M in gross proceeds through an offering.
